Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

William R. Hiatt, Giant of Vascular Medicine, Dies at 70

News Daily News

William R. Hiatt, Giant of Vascular Medicine, Dies at 70

December 11, 2020

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

September 18, 2020

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

June 25, 2020

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

News Daily News

Kenneth Kent, Angioplasty Pioneer and Original TCT Co-Director, Dies at 81

Yael L. Maxwell

May 22, 2020

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

News Daily News

COVID-19 in NYC: CV Risk Factors and Bleak Outcomes in the Critically Ill

Michael O'Riordan

May 19, 2020

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

News Daily News

COVID-19’s Lopsided Impact on Minorities Should ‘Ignite’ Reform, Experts Say

Yael L. Maxwell

April 20, 2020

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

News Daily News

COMPASS Antithrombotic Approach Works Well in Prior-PCI Patients

March 27, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

January 20, 2020

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.